North America Transfection Reagents and Equipment Market – Industry Trends and Forecast to 2025

  • In Vitro Diagnostics
  • Published Report
  • Mar 2017
  • North America
  • 124 Pages
  • No of Tables: 24
  • No of Figures: 62

North America Transfection Reagents and Equipment Market, By Product (Reagents, Equipment), By Method (Physical Method, Biochemical Methods, Viral Methods), By Application (Protein Production, Biomedical Research, Therapeutic Delivery), By End User (Academics & Research Institutes, Pharmaceutical & Biotechnology Companies), By End User, By Country (U.S.A, Canada, Mexico) – Industry Trends and Forecast to 2024

North America Transfection Reagents and Equipment Market is expected to hold the leading market share in the forecast period of 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Prominent factors driving the growth of this market consist of technology advancements in the transfection technology, rising prevalence of chronic cases, increase in demand of chimeric genes growing alliances between the leading research institutes to trigger drug discovery, increasing R&D spending and research activities by pharmaceutical and biotech companies and rising research activities in cell science.

Market Segmentation: North America Transfection Reagents and Equipment Market 

  • The North America transfection reagents and equipment market is segmented based on products into two segments; reagents and equipment. In 2018, reagents segment is estimated to rule with 78.7% shares, rising at a specified CAGR. However, equipment is growing at the highest CAGR in the forecast period of 2018 to 2025.
  • The North America transfection reagents and equipment market is segmented based on method categories into three segments; biochemical methods, physical and viral method. In 2018, physical segment is valued to rule with highest market shares, rising at the highest CAGR.  Physical segment is dominating the market as it was the initial choice for the transfection and highly efficient. Physical method is further sub segmented into electroporation, nucleofection and others. Other physical method is further divided into genegun, magnetofection, sonoporation and optoinjection. Biochemical method is segmented into lipofection, calcium phosphate, deae-dextran and dendrimers. Viral method is divided into 4 sub segments including adenoviruses, retroviruses, adeno associated viruses and others.
  • Based on application, the North America transfection reagents and equipment market is segmented into biomedical research, protein production and therapeutic delivery. In 2018, protein production segment is projected to rule with the highest market shares, rising at the highest CAGR. Protein production is dominating the market as protein is essential requirement for food, healthcare and cosmetics so the protein production is the major application of transfection procedure. Biomedical application is further sub segmented into gene expression studies, cancer research and transgenic models.
  • The North America transfection reagents and equipment market is segmented based on end user into two notable segments; academics & research institutes and pharmaceutical & biotechnology companies. In 2018, academics & research institutes segment is likely to rule with highest market shares, rising at the highest CAGR. The academics & research institutes are dominating the market as more research is being carried out in research organizations. And research organizations later on licensed out to industries for further development of products.

Key Drivers: North America Transfection Reagents and Equipment Market 

Prominent factors driving the growth of this market consist of technology advancements in the transfection technology, rising prevalence of chronic cases, increase in demand of chimeric genes growing alliances between the leading research institutes to trigger drug discovery, increasing R&D spending and research activities by pharmaceutical and biotech companies and rising research activities in cell science.

Key Points: North America Transfection Reagents and Equipment Market 

Thermo Fisher Scientific Inc. is expected to dominate the North America transfection reagents and equipment market followed by Sigma-Aldrich, Inc (distributor of F. Hoffman La. Roche) followed by Promega Corporation., QIAGEN.

  • The reagent segment is dominating the North America transfection reagents and equipment market.
  • Equipment segment is expected to grow with the highest CAGR of 9.0% in the forecast period 2018 to 2025.

SKU-

TABLE OF CONTENTS NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED
2.2 GEOGRAPHIC SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 RESEARCH METHODOLOGY
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 THE CATEGORY VS TIME GRID
2.8 SECONDARY SOURCES
2.9 ASSUMPTIONS

3 MARKET OVERVIEW

3.1 DRIVERS

3.1.1 RISING RESEARCH ACTIVITIES IN CELL SCIENCE AND INCREASE IN DEMAND OF CHIMERIC GENES
3.1.2 INCREASING R&D SPENDING AND RESEARCH ACTIVITIES BY PHARMACEUTICAL AND BIOTECH COMPANIES
3.1.3 TECHNOLOGICAL ADVANCEMENTS IN TRANSFECTION TECHNOLOGY
3.1.4 ALLIANCES BETWEEN THE LEADING RESEARCH INSTITUTES TO TRIGGER DRUG DISCOVERY
3.1.5 RISING PREVALENCE OF CHRONIC INDICATIONS

3.2 RESTRAINTS

3.2.1 SELECTIVE EFFECTIVENESS OF TRANSFECTION REAGENTS OR INSTRUMENTS
3.2.2 HIGH COST OF TRANSFECTION REAGENTS AND EQUIPMENT
3.2.3 HOME BREW REAGENTS LIMITS THE SALE OF COMMERCIAL KITS

3.3 OPPORTUNITIES

3.3.1 EFFICIENT NUCLEAR DELIVERY METHOD
3.3.2 EMERGING MARKETS

3.4 CHALLENGES

3.4.1 SLOW RATE OF TRANSFECTION IN HARD CELLS
3.4.2 CYTOTOXICITY EFFECTS DUE TO TRANSFECTION REAGENTS

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

6 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY PRODUCT

6.1 OVERVIEW
6.2 REAGENT
6.3 EQUIPMENT

7 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY METHOD

7.1 OVERVIEW

7.2 PHYSICAL METHOD

7.2.1 ELECTROPORATION

7.2.2 NUCLEOFECTION

7.2.3 OTHERS

7.2.3.1 GENEGUN
7.2.3.2 MAGNETOFECTION
7.2.3.3 SONOPORATION
7.2.3.4 OPTOINJECTION

7.3 BIOCHEMICAL METHODS

7.3.1 LIPOFECTION
7.3.2 CALCIUM PHOSPHATE
7.3.3 DEAE-DEXTRAN
7.3.4 DENDRIMERS

7.4 VIRAL METHOD

7.4.1 RETROVIRUSES
7.4.2 ADENOVIRUSES
7.4.3 ADENOASSOCIATED VIRUSES
7.4.4 OTHERS

8 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY APPLICATION

8.1 OVERVIEW

8.2 PROTEIN PRODUCTION

8.3 BIOMEDICAL RESEARCH

8.3.1 GENE EXPRESSION STUDIES
8.3.2 CANCER RESEARCH
8.3.3 TRANSGENIC MODELS

8.4 THERAPEUTIC DELIVERY

9 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY END USER

9.1 OVERVIEW
9.2 ACADEMICS & RESEARCH INSTITUTES
9.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES

10 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT, BY GEOGRAPHY

10.1 NORTH AMERICA

10.1.1 U.S.
10.1.2 CANADA
10.1.3 MEXICO

11 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET, COMPANY LANDSCAPE

11.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

12 COMPANY PROFILE

12.1 THERMO FISHER SCIENTIFIC INC.

12.1.1 COMPANY OVERVIEW
12.1.2 REVENUE ANALYSIS
12.1.3 COMPANY SHARE ANALYSIS
12.1.4 PRODUCT PORTFOLIO
12.1.5 RECENT DEVELOPMENTS

12.2 SIGMA-ALDRICH, INC. (SUBSIDIARY OF MERCK KGAA)

12.2.1 COMPANY OVERVIEW
12.2.2 GEOGRAPHICAL PRESENCE
12.2.3 COMPANY SHARE ANALYSIS
12.2.4 PRODUCT PORTFOLIO
12.2.5 RECENT DEVELOPMENTS

12.3 PROMEGA CORPORATION

12.3.1 COMPANY OVERVIEW
12.3.2 GEOGRAPHICAL PRESENCE
12.3.3 COMPANY SHARE ANALYSIS
12.3.4 PRODUCT PORTFOLIO
12.3.5 RECENT DEVELOPMENTS

12.4 QIAGEN

12.4.1 COMPANY OVERVIEW
12.4.2 REVENUE ANALYSIS
12.4.3 COMPANY SHARE ANALYSIS
12.4.4 PRODUCT PORTFOLIO
12.4.5 RECENT DEVELOPMENTS

12.5 BIO-RAD LABORATORIES, INC.

12.5.1 COMPANY OVERVIEW
12.5.2 REVENUE ANALYSIS
12.5.3 PRODUCT PORTFOLIO
12.5.4 RECENT DEVELOPMENTS

12.6 GENLANTIS INC.

12.6.1 COMPANY OVERVIEW
12.6.2 GEOGRAPHICAL PRESENCE
12.6.3 PRODUCT PORTFOLIO
12.6.4 RECENT DEVELOPMENTS

12.7 LONZA

12.7.1 COMPANY OVERVIEW
12.7.2 REVENUE ANALYSIS
12.7.3 PRODUCT PORTFOLIO
12.7.4 RECENT DEVELOPMENTS

12.8 MAXCYTE INC

12.8.1 COMPANY OVERVIEW
12.8.2 GEOGRAPHICAL PRESENCE
12.8.3 PRODUCT PORTFOLIO
12.8.4 RECENT DEVELOPMENTS

12.9 MIRUS BIO LLC

12.9.1 COMPANY OVERVIEW
12.9.2 GEOGRAPHICAL PRESENCE
12.9.3 PRODUCT PORTFOLIO
12.9.4 RECENT DEVELOPMENTS

12.10 POLYPLUS TRANSFECTION

12.10.1 COMPANY OVERVIEW
12.10.2 GEOGRAPHICAL PRESENCE
12.10.3 PRODUCT PORTFOLIO
12.10.4 RECENT DEVELOPMENTS

12.11 SIGNAGEN LABORATORIES.

12.11.1 COMPANY OVERVIEW
12.11.2 GEOGRAPHICAL PRESENCE
12.11.3 PRODUCT PORTFOLIO
12.11.4 RECENT DEVELOPMENT

13 RELATED REPORTS

LIST OF TABLES NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET 

TABLE 1 LIST OF CANCEROUS CELL LINE PRODUCED BY THERMO FISHER INC

TABLE 2 COST OF FEW TRANSFECTION REAGENTS OF POLYSCIENCES, INC.

TABLE 3 COST OF FEW TRANSFECTION REAGENTS OF THERMO FISHER INC.

TABLE 4 COST OF ELECTROPORATION INSTRUMENTS & ACCESSORIES:

TABLE 5 COST OF FEW TRANSFECTION REAGENTS OF SOURCE BIOSCIENCE

TABLE 6 HEALTHCARE EXPENDITURE IN ASIA PACIFIC (USD MILLION)

TABLE 7 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY PRODUCT, 2016-2025 (USD MILLION)

TABLE 8 NORTH AMERICA REAGENTS IN TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 9 NORTH AMERICA EQUIPMENT IN TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 10 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY METHOD, 2016-2025, (USD MILLION)

TABLE 11 NORTH AMERICA PHYSICAL METHOD IN TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY METHOD, 2016-2025 (USD MILLION)

TABLE 12 NORTH AMERICA PHYSICAL METHOD IN TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 13 NORTH AMERICA OTHER PHYSICAL METHODS IN TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY METHOD, 2016-2025 (USD MILLION)

TABLE 14 NORTH AMERICA BIOCHEMICAL METHODS IN TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY METHOD, 2016-2025 (USD MILLION)

TABLE 15 NORTH AMERICA BIOCHEMICAL METHODS IN TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 16 NORTH AMERICA VIRAL METHOD IN TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY METHOD, 2016-2025 (USD MILLION)

TABLE 17 NORTH AMERICA VIRAL METHOD IN TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 18 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY APPLICATION, 2016-2025, (USD MILLION)

TABLE 19 NORTH AMERICA PROTEIN PRODUCTION IN TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY REGION , 2016-2025 (USD MILLION)

TABLE 20 NORTH AMERICA BIOMEDICAL RESEARCH IN TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 21 NORTH AMERICA BIOMEDICAL RESEARCH IN TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 22 NORTH AMERICA THERAPEUTIC DELIVERY IN TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 23 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY END USER, 2016-2025 (USD MILLION)

TABLE 24 NORTH AMERICA ACADEMICS & RESEARCH INSTITUTES IN TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 25 NORTH AMERICA PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 26 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY COUNTRY, USD MILLION (2016-2025)

TABLE 27 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY PRODUCTS, 2016-2025 (USD MILLION)

TABLE 28 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY METHODS, 2016-2025 (USD MILLION)

TABLE 29 NORTH AMERICA PHYSICAL METHOD IN TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY METHODS, 2016-2025 (USD MILLION)

TABLE 30 NORTH AMERICA OTHER PHYSICAL METHODS IN TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY METHODS, 2016-2025 (USD MILLION)

TABLE 31 NORTH AMERICA BIOCHEMICAL METHODS IN TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY METHODS, 2016-2025 (USD MILLION)

TABLE 32 NORTH AMERICA VIRAL METHODS IN TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY METHODS, 2016-2025 (USD MILLION)

TABLE 33 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 34 NORTH AMERICA BIOMEDICAL RESEARCH IN TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 35 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY END USER, 2016-2025 (USD MILLION)

TABLE 36 U.S. TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY PRODUCTS, 2016-2025 (USD MILLION)

TABLE 37 U.S. TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY METHODS, 2016-2025 (USD MILLION)

TABLE 38 U.S. PHYSICAL METHOD IN TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY METHODS, 2016-2025 (USD MILLION)

TABLE 39 U.S. OTHER PHYSICAL METHODS IN TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY METHODS, 2016-2025 (USD MILLION)

TABLE 40 U.S. BIOCHEMICAL METHODS IN TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY METHODS, 2016-2025 (USD MILLION)

TABLE 41 U.S. VIRAL METHODS IN TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY METHOD, 2016-2025 (USD MILLION)

TABLE 42 U.S. TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 43 U.S. BIOMEDICAL RESEARCH IN TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 44 U.S. TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY END USER, 2016-2025 (USD MILLION)

TABLE 45 CANADA TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY PRODUCTS, 2016-2025 (USD MILLION)

TABLE 46 CANADA TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY METHODS, 2016-2025 (USD MILLION)

TABLE 47 CANADA PHYSICAL METHOD IN TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY METHODS, 2016-2025 (USD MILLION)

TABLE 48 CANADA OTHER PHYSICAL METHODS IN TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY METHODS, 2016-2025 (USD MILLION)

TABLE 49 CANADA BIOCHEMICAL METHODS IN TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY METHODS, 2016-2025 (USD MILLION)

TABLE 50 CANADA VIRAL METHODS IN TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY METHODS, 2016-2025 (USD MILLION)

TABLE 51 CANADA TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 52 CANADA BIOMEDICAL RESEARCH IN TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 53 CANADA TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY END USER, 2016-2025 (USD MILLION)

TABLE 54 MEXICO TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY PRODUCTS, 2016-2025 (USD MILLION)

TABLE 55 MEXICO TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY METHODS, 2016-2025 (USD MILLION)

TABLE 56 MEXICO PHYSICAL METHOD IN TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY METHODS, 2016-2025 (USD MILLION)

TABLE 57 MEXICO OTHER PHYSICAL METHODS IN TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY METHODS, 2016-2025 (USD MILLION)

TABLE 58 MEXICO BIOCHEMICAL METHODS IN TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY METHODS, 2016-2025 (USD MILLION)

TABLE 59 MEXICO VIRAL METHODS IN TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY METHODS, 2016-2025 (USD MILLION)

TABLE 60 MEXICO TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 61 MEXICO BIOMEDICAL RESEARCH IN TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 62 MEXICO TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY END USER, 2016-2025 (USD MILLION)

LIST OF FIGURES NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET

FIGURE 1 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET: SEGMENTATION

FIGURE 2 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET: DATA TRIANGULATION

FIGURE 3 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET: RESEARCH SNAPSHOT

FIGURE 4 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET BOTTOM UP APPROACH

FIGURE 5 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET TOP DOWN APPROACH

FIGURE 6 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET: BIOCHEMICAL METHODS

FIGURE 8 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET: PHYSICAL METHODS

FIGURE 9 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET: VIRAL METHODS

FIGURE 10 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET

FIGURE 11 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET: SEGMENTATION

FIGURE 12 RISING RESEARCH ACTIVITIES IN CELL SCIENCE AND INCREASE IN DEMAND OF CHIMERIC GENES ARE EXPECTED TO DRIVE THE MARKET FOR NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT IN THE FORECAST PERIOD 2018 TO 2025

FIGURE 13 REAGENTS IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET IN 2018 & 2025

FIGURE 14 ASIA PACIFIC IS THE MAXIMUM GROWING AND MOST PROFITABLE REVENUE POCKETS FOR TRANSFECTION REAGENTS AND EQUIPMENT MARKET IN THE FORECAST PERIOD FROM 2018 TO 2025

FIGURE 15 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET: BY PRODUCT, 2017

FIGURE 16 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET: BY METHOD, 2017

FIGURE 17 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET: BY APPLICATION, 2017

FIGURE 18 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET: BY END USER, 2017

FIGURE 19 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET SNAPSHOT (2017)

FIGURE 20 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT: BY COUNTRY (2017)

FIGURE 21 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT: BY COUNTRY (2018 & 2025)

FIGURE 22 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET BY COUNTRY (2017 & 2025)

FIGURE 23 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY PRODUCTS (2018 TO 2025)

FIGURE 24 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET: COMPANY SHARE 2017 (%)

Please fill in the below form for detailed Inquire Before Buying

Choose License Type
  • $3200.00
  • $2500.00
BUY NOW ADD TO CART